Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4205831
Max Phase: Preclinical
Molecular Formula: C21H15F2N5O2
Molecular Weight: 407.38
Molecule Type: Small molecule
Associated Items:
ID: ALA4205831
Max Phase: Preclinical
Molecular Formula: C21H15F2N5O2
Molecular Weight: 407.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccnc(NC(=O)c2cc(C(F)(F)c3cncnc3)cc3cccnc23)c1
Standard InChI: InChI=1S/C21H15F2N5O2/c1-30-16-4-6-26-18(9-16)28-20(29)17-8-14(7-13-3-2-5-27-19(13)17)21(22,23)15-10-24-12-25-11-15/h2-12H,1H3,(H,26,28,29)
Standard InChI Key: ZUKQQYGHLFIREM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 407.38 | Molecular Weight (Monoisotopic): 407.1194 | AlogP: 3.82 | #Rotatable Bonds: 5 |
Polar Surface Area: 89.89 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.49 | CX Basic pKa: 4.15 | CX LogP: 2.87 | CX LogD: 2.87 |
Aromatic Rings: 4 | Heavy Atoms: 30 | QED Weighted: 0.54 | Np Likeness Score: -1.12 |
1. Felts AS, Rodriguez AL, Morrison RD, Blobaum AL, Byers FW, Daniels JS, Niswender CM, Conn PJ, Lindsley CW, Emmitte KA.. (2018) Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5., 28 (10): [PMID:29705142] [10.1016/j.bmcl.2018.04.053] |
Source(1):